Utah passes biosimilar substitution law
Utah has become the latest US state to approve “interchangeable” biosimilar use.
Archives for April 2, 2015
Pfizer: 'No biosimilar interchangeability in near future'
Data must drive US FDA efforts to determine biosimilar interchangeability according to a Pfizer exec who told Goldman Sachs conference delegates not to expect a definition anytime soon.
$5m private funding for PlasmaTech Biopharmaceuticals downstream tech
A company which filters human blood plasma to make biologic drugs has raised $5m to develop its (factor-making) tech.
US military strikes deal to secure adenovirus shots from Teva
Supply of the Adenovirus Type 4 and Type 7 Vaccine to all US military personnel has been secured through a five-year contract with Teva worth $170m (€156m).